ÐÓ°ÉÔ­´´

A new $2.5 million grant from the National Institutes of Health is enabling ÐÓ°ÉÔ­´´ chemist Renã A.S. Robinson to expand her research on racial disparities in Alzheimer’s and other diseases. Read More

Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.

Angela Jefferson, PhD, professor of Neurology and director of the ÐÓ°ÉÔ­´´ Memory and Alzheimer’s Center, has been awarded a $3.7 million, three-year grant from the National Institute on Aging (NIA) to support establishment of a prospective NIA-funded Alzheimer’s Disease Research Center (ADRC) at ÐÓ°ÉÔ­´´ Medical Center.

Women with three or more uterine fibroids — non-cancerous growths — during pregnancy are more likely to have infants with reduced birthweight and may need additional surveillance.

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.

Combining studies of genetically diverse mouse populations and human data led to the identification of a gene associated with cognitive decline and brain changes in Alzheimer’s disease.

Tina Iverson and colleagues provide a structural view into the assembly of a protein machine essential for cellular energy production.

A new study sheds new light on the challenges facing African American women. More than half of all African American women in the United States report having at least one family member who is incarcerated, causing higher levels of depressive symptoms and psychological distress than previously understood. Read More

When it comes to creating successful business interactions, exchanges between buyers and sellers with similar emotional abilities may lead to more lucrative outcomes than an animated or ambitious employee alone. Read More

Physician-scientists at ÐÓ°ÉÔ­´´ Medical Center are investigating whether SARS-CoV-2, the virus that causes COVID-19, can be spread through aerosolized emissions (microscopic droplets and particles) during minimally invasive surgery in children.

Taking an interest in electronic message threads between surgical patients and their health care teams, a research group at ÐÓ°ÉÔ­´´ Medical Center has tested how well certain commonly used machine learning algorithms can classify such exchanges according to their clinical decision-making complexity.

At a time when Americans are voicing their opinions at the ballot box and in other ways, ÐÓ°ÉÔ­´´ is joining people across Tennessee and the nation in commemorating the centennial of the long-fought battle to secure a woman’s constitutional right to vote. Read More

Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.

Surgical patients are being given more opioids than they need for postsurgical pain management, raising the risk of addiction.

ÐÓ°ÉÔ­´´ Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.

Excess dietary salt activates immune cells to induce inflammation and hypertension, supporting current recommendations for low sodium consumption.

ÐÓ°ÉÔ­´´ scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.

A small-molecule “scavenger” that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at ÐÓ°ÉÔ­´´ Medical Center.

Researchers at ÐÓ°ÉÔ­´´ Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern.

While 60 percent of people with metastatic melanoma, an aggressive type of skin cancer, have multiple treatment options available to them, roughly 40 percent either do not respond to treatment, or relapse.